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Methods and results: Characteristics, treatments and 30-day mortality were
recorded for 1408/1901 consecutive ACS patients. Changes in global model fit,
discrimination, calibration and reclassification were evaluated upon addition of
CRP to the GRACE risk score. High-CRP patients (CRP >22 mg/L, 4th quartile of
CRP) were older, had more comorbidities and worse hemodynamic conditions,
received less recommended treatment and had a four-fold higher 30 day mortality.
Multivariable analysis demonstrated high-CRP as an important and independent
predictor of mortality. Addition of high-CRP in the GRACE model improved
global fit, discriminatory capacity and calibration. Patients were divided into 4
groups according to GRACE risk score prediction: <1%, 1 to <5%, 5 to <10% and
>=10%. The model with high-CRP allowed adequate reclassification in 12.2%.
Conclusions: Elevated CRP level is an independent and important predic-
tive factor of 30-day mortality in ACS patients, even after adjustment for co-
morbidities, hemodynamic conditions and treatment. Combined with the
GRACE risk score, CRP information improves risk classification.
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Kais Battikh, Maher Souissi, M Lotfi Slimane
CHU Habib Thameur Tunis, Cardiologie, Tunis, Tunisie
Percutaneous coronary intervention (PCI) of the coronary chronic total
occlusion (CTO) is widely discussed because of the difficulty and the risks of
the procedure and the controversial but very interesting clinical benefit in case
of procedure success.
Objective: To evaluate the in-hospital and long-term clinical outcome of
PCI in the case of CTO and measure the adverse effects and complications.
Methods: 62 cases of PCI for a CTO were consecutively registered from
January 2005 to February 2009. In addition to an assessment of the technical
characteristics and procedural outcomes, patients were followed for occurrence
of major adverse cardiac events (MACE). These patients are distributed in two
groups: (A) for the occlusion between 1 and 3 months age and (B) for the occlu-
sion of more than 3 months age. RESULTS: 68 lesions were treated in these 62
patients (47 male and 15 female) with mean age of 59 years (40-80). 42% of
theses patients were diabetics, 48% smoker and 26% with hypertension. 27
patients had an ST elevation acute coronary syndrome (ACS) and 24 a non ST
elevation ACS, where 2 had stable angina. Balloon angioplasty was performed
in only 4 cases and the stenting in 58 cases with use of 64 stents (average of 1.1
stent / artery and of 1.2 stent / patient), we used drug eluting stent in only 10
case (15.6 %). Total procedure success rate, defined by a patent artery (less then
30% residual stenosis) with TIMI 3 flow (grade 3) at the end of the PCI was 83
%( 57/68) . The success was better in the group A 90% (29/32) then the group
B 77% (28/36) (P < 0.05). The most frequent cause of procedure failures was
unsuccessful crossing with the wire in 6 cases and no severe acute complications
were done. Theses CTO required long procedures with an average time of fluo-
roscopy of 30 ’ 13 ", an average calculated dose radiation DAP of 20611 cGy /
cm2 and a high mean amount of contrast media 289.46 ml. At the preliminary
clinical results, patients with successful PCI of a CTO had a significantly better
clinical outcome than those whose PCI was unsuccessful.
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Previous studies have shown that heart rate is a predictor of coronary
events and cardiovascular mortality. Moreover, pathophysiological studies
indicate that a relatively high heart rate has detrimental effects on the progres-
sion of coronary atherosclerosis. Heart transplant recipients frequently have
sinus tachycardia related to cardiac denervation. Therefore we evaluated the
prognostic importance of heart rate in heart transplant recipients.
143 consecutive heart transplant recipients (age at transplantation: 48.5±13
years) with at least a 2 year survival after transplantation were studied with a
9.5 year mean follow-up (range 2-23 years). Basal heart rate was measured at
rest 3 months after heart transplantation in the absence of beta-blocker therapy
or acute rejection. Survival without cardiac event was compared between
patients with basal heart rate < or >95/min (median) according to Kaplan-
Meier method using log-rank test.
Fifty-six patients had coronary irregularities or stenoses at routine biennal
coronary angiography and 87 had angiographically normal coronary arteries
during the follow-up. Mean basal heart rate did not significantly differ between
these two groups (96.4/min vs 98.3/min p=0.34). Twenty-seven patients had a
coronary event (myocardial infarction, percutaneous coronary intervention or
coronary death). Survival without coronary event did not significantly differ
between patients with basal heart rate > or < 95/min (logrank p= 0,97).
Conclusion: This series does not support a prognostic influence of heart
rate for cardiac allograft vasculopathy or coronary events in heart transplant
recipients.
049
Marked reduction of operator radiation exposure by using a patient
lead cover during coronary angiography or percutaneous intervention
Bogdan Radulescu (1), Pauline Bouyer (2), Luc Mertz (2), Olivier Morel
(1), Michel Zupan (1), Pierre Bareiss (1), François Bronner (1), André
Constantinesco (2), Patrick Ohlmann (1)
(1) Hôpitaux Universitaires de Strasbourg, Pôle cardiovasculaire, Stras-
bourg, France – (2) Hôpitaux Universitaires de Strasbourg, Médecine
nucléaire, Strasbourg, France
Background: Operators and patient radiation exposure during interven-
tional cardiology procedures may induce radiation injury and may increase
risk of cancer.
Objectives: To determine the effectiveness of a lead cover placed over the
patient abdomen and groins in reducing operator radiation exposure during
coronary intervention.
Methods: Radiation exposure measurements were performed over an 8
weeks period, in patients undergoing diagnostic and/or interventional coronary
procedures. Usual protection of the operator was ensured using a lead apron, low
leaded flaps, and leaded glass. Each of three procedures was realized using a
lead cover placed on the patient abdomen. Operator irradiation was assessed by
using 3 electronic dosimeters placed over the apron on the chest and in the back
(no 1, 2) on the left arm (no 3). Patient radiation exposure (using the diamentor
system), ambiental irradiation (using an electronic dosimeter placed in the room
opposite to the Xray tube) and fluoroscopy times were recorded. Results are pre-
sented in mean ± SEM and comparisons assessed by student t test.
Results: Operator exposure was assessed during 189 procedures (136 coronary
angiograms and 53 percutaneous coronary interventions) in 71 cases (37%) with
the lead cover over the patient (group 1) and in 118 cases (63%) without it (group
2). Fluoroscopy times, dose area products and ambient irradiation were similar
with and without the lead cover (4 ± 2 vs 4.1 ± 0.6 min, 55,7 ± 5,8 vs 57,6 ± 4,2
Gy cm2 and 0.7 ± 0.2 vs 0.8 ± 0.1 μSv respectively – p > 0.05). However, operator
irradiation was markedly decreased by using the lead cover: from 19.2 ± 3.1 to 4.9
± 0.9 μSv at the chest level (p=0,001), from 1.8 ± 0.3 to 0.3 ± 0.1 μSv at the back
(p=0.002) and from 25.8 ± 4.7 to 10.2 ± 2.2 μSv at the left arm (p=0,019).
Conclusions: Using a lead cover placed over the patient is highly effective
in attenuating operator scatter radiation exposure during coronary procedure.
Such additional protection device might be useful either in the perspective of
long duration procedure or in routine use.
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Background: Percutaneous coronary intervention (PCI) is the cornerstone of
revascularization in acute coronary syndromes (ACS). The radial artery cathete-
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rization (RAC) is associated with less bleeding complications. However it is not
clear whether the benefit on bleedings associated with RAC could be translated
into a reduction of long term major adverse cardiovascular events (MACE). In
patients with ST elevation myocardial infarction (STEMI), we have to determine
if the use of RAC allows the recanalization of the coronary artery in a timely
fashion. We aimed to confirm that RAC reduces haemorrhagic complications
and determine if this advantage on bleedings could be translated into a 6 months
MACE reduction. We also checked if RAC did not lengthen the time puncture
to balloon (TPB) in the subgroup of STEMI patents.
Methods: All patients hospitalized for an ACS and treated with PCI
between 01/2008 and 12/2008 were considered for this study. Predictors of in
hospital minor and major bleedings and 6 months MACE were sought by uni
and multivariate analysis.
Results: Altogether, 626 patients were included. 509 treated with RAC
and 117 with a femoral artery catheterization (FAC). As compared to FAC,
RAC decreased in hospital minor and major bleedings, respectively by 80
%(OR=0.2, CI=0.06-0.6, p=0,004) and 74 % (OR=0.26, CI=0.1-0.7,
p=0,007). In patients with STEMI, there was no difference in TPB whatever
the arterial access used (13 min vs 14 min, p=0.7). At 6 months, RAC was
found as an independent predictor for less MACE (OR=0.4, CI=0.1-1.1,
p=0.05).
Conclusion: Patients treated by PCI derive benefit from the use of RAC on
in-hospital bleedings but also on the reduction of 6 months ischemic events. In
STEMI patients it does not extend the TPB. Use of RAC should have a wides-
pread diffusion.
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It is now well accepted that an elevated blood glucose level is associated
with increased mortality in patients presenting with acute myocardial infarc-
tion (AMI). However, the underlying mechanisms of these deleterious effects
of hyperglycemia are not well understood. Impaired microvascular function, or
the no-reflow phenomenon may be one of these factors.
Objectives: We investigated the association between hyperglycemia and
the no-reflow phenomenon in patients with AMI.
Results: A total of 250 patients presenting with AMI were evaluated.
The no-reflow phenomenon was found in 29 (11.6 %) patients, their glu-
cose level on hospital admission was significantly higher than patients who did
not exhibit this phenomenon (16.5 ± 9.3 vs. 12. 2 ± 7.1 mmol/l; p = 0.008).
There was no difference in patients characteristics except for diabetes (51.7%
vs. 29.7% ;p=0.017). Maximum level of creatine kinase (CK) were signifi-
cantly higher in patients with no-reflow (4320 ± 1981 vs. 2980.3 ±1955 IU,
p= 0.01).
Patients with no-reflow presented more frequently with heart failure
(44.8% vs. 14.1%;p<0.01).
In multivariate analysis the blood glucose level was an independent pro-
gnostic factor for no-reflow (OR: 1.8; 95% CI: 1.2-4, p <0.01).
Conclusions: Hyperglycemia might be associated with impaired microvas-
cular function after AMI, resulting in a larger infarct size and worse functional
recovery.
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Objectives: ST segment resolution (STR) is a recognized intermediate pro-
gnosis parameter in STEMI reflecting the quality of tissue reperfusion. The
aim of our study was to identify clinical, biological and angiographic determi-
nants of STR.
Methods: 157 consecutive patients treated by primary PCI within 6 hours
of symptom onset were included. STR was calculated in the lead with
maximal ST segment elevation. Complete STR was defined as a regression
more than 70%.
Results: Mean age of the population was 58,7±13,7 ans, the sex ratio 4
men for one woman. Maximal ST segment elevation was 0,33Â±0,18 mV
before and 0,16Â±0,19 mV 59Â± minutes after PCI. Complete STR was
achieved in 43,3% of patients. STR significantly correlated with enzymatic
peak CPK (r= -0,33 p<0,00001), peak troponine I (r= -0,26 p=0,01), echo-
graphic LVEF (r=0,35 p<0,0001) and plasmatic creatinin concentration 48
hours after admission (r= -0,31 p=0,0001). In univariate analysis, complete
STR was significantly associated with young age, an elevated SpO2, angio-
graphic TIMI flow grade 2 or 3 before angioplasty, low plasmatic BNP or
HbA1c or fibrinogen concentrations. A trend of association for complete
STR was observed with Killip class (p=0,075), number of Q waves
(p=0,075), the use of direct stenting (p=0,08) and the use of abciximab
(p=0,07). In multivariate analysis the independant predictors of STR were
inferior location of infarction (OR=1,35 ; IC 1,16-1,55), TIMI risk score<5
(OR=1,24 ; IC 1,05-1,59) and angiographic TIMI flow grade 2 or 3 before
angioplasty (OR=1,07 IC 1,009-1,15).
Conclusion: Our results suggest that STR is related to the size of myocar-
dial infarction. The resolution of ST elevation is multifactorial and mainly
deriven by inferior location of myocardial infarction, low TIMI risk score and
better angiographic TIMI flow grade before PCI (>1).
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Introduction: Women until menopause remains protected from coronary
artery disease, and its epidemiology is different from that in men.
Objective: The aim of this work is to assess the prevalence, clinical and
biological features of acute coronary syndrome of Algerian women compared
to men.
Materiel and method: This is a retrospective study, descriptive, conducted
in our cardiology department near the patients hospitalized in intensive care
unit cardiac, from 1/12 2006 to 30/ 04/2008 for ACS.A total of 413 patients is
included, with 276 men (66.83%) and 137 women (33.17%) aged 20 to 101
years with an average age of 60.80 years.
Results: In univariate analysis: the Algerian woman is older, occurring
mainly in an array of SCA (ST-),is more often diabetic, hypertensive, ove-
rweight (waist circumference and BMI).There is also a disturbance renal func-
tion more marked, blood glucose and lipid more troubled. The Algerian man
has a far more important smoking and ventricular systolic dysfunction more
severe.
In multivariate analysis: the only parameters that appear significant in
women are: ACS (ST-) (or:0.3.046ci:1.78-5.20 p:0.000), smoking
(or:13.182 ci:5.982-29.052 p:0.000)and diabetes google(or:0.543 ci:0.319-
0.923 p:0.024).
Discussion: Algerian women has different clinical and biological cha-
racteristics in relation to the algerian man who require levels of care dif-
ferent.
